Cited by 485Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.

The presenilin hypothesis of Alzheimer’s disease: Evidence for a loss-of-function pathogenic mechanism.

Open access

Shen, Jie, Kelleher, Raymond J.·2007·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0608332104PMC PMC1766397

Open this paper in CoChat — free account

Abstract

Dominantly inherited mutations in the genes encoding presenilins (PS) and the amyloid precursor protein (APP) are the major causes of familial Alzheimer's disease (AD). The prevailing view of AD pathogenesis posits that accumulation of β-amyloid (Aβ) peptides, particularly Aβ42, is the central event triggering neurodegeneration. Emerging evidence, however, suggests that loss of essential functions of PS could better explain dementia and neurodegeneration in AD. First, conditional inactivation of PS in the adult mouse brain causes progressive memory loss and neurodegeneration resembling AD, whereas mouse models based on overproduction of Aβ have failed to produce neurodegeneration. Second, whereas pathogenic PS mutations enhance Aβ42 production, they typically reduce Aβ40 generation and impair other PS-dependent activities. Third, γ-secretase inhibitors can enhance the production of Aβ42 while blocking other γ-secretase activities, thus mimicking the effects of PS mutations. Finally, PS mutations have been identified in frontotemporal dementia, which lacks amyloid pathology. Based on these and other observations, we propose that partial loss of PS function may underlie memory impairment and neurodegeneration in the pathogenesis of AD. We also speculate that Aβ42 may act primarily to antagonize PS-dependent functions, possibly by operating as an active site-directed inhibitor of γ-secretase.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0608332104

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Self-citation
Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration
Saura, C. A., Choi, S.-Y., Beglopoulos, V., Malkani, S., Zhang, D., Rao, B. S. S., Chattarji, S., Kelleher, R. J., Kandel, E. R., Duff, K., et al. (2004) · Neuron · doi:10.1016/s0896-6273(04)00182-5 · Cited by 757
Self-citation
A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions
Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V., Baki, L., Wen, P., Efthimiopoulos, S., Shao, Z., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1948 · Cited by 686
APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations
Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S.-F., Hao, Y.-H., Serneels, L., De Strooper, B., Yu, G., & Bezprozvanny, I. (2006) · Cell · doi:10.1016/j.cell.2006.06.059 · Cited by 616

Show all 62 references

Sorted by citations

Items 201–300 of 484

Presenilin 2 N141I mutation induces hyperactive immune response through the epigenetic repression of REV-ERBα
Nam, H., Lee, Y., Kim, B., Lee, J.-W., Hwang, S., An, H., Chung, K. M., Park, Y., Hong, J., Kim, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29653-2 · Cited by 33
Function and Dysfunction of Presenilin
Shen, J. (2013) · Neurodegenerative Diseases · doi:10.1159/000354971 · Cited by 32
Self-citation
Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems
Hunter, S., & Brayne, C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt108 · Cited by 31
Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)
Aguilar, L. R., Acosta‐Uribe, J., Giraldo, M., Moreno, S., Baena, A. Y., Alzate, D., Cuastumal, A. R., Aguillon, D. F., Madrigal, L., Saldarriaga, A., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.010 · Cited by 31
Early-Onset Familial Alzheimer Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype
Fung, S., Smith, C. S., Prater, K. E., Case, A., Green, K., Osnis, L., Winston, C. N., Kinoshita, Y., Sopher, B. L., Morrison, R. S., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200492 · Cited by 33
Loss of presenilin function enhances tau phosphorylation and aggregation in mice
Soto-Faguás, C. M., Sanchez-Molina, P., & Saura, C. A. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01259-7 · Cited by 30
Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives
Bhole, R. P., Chikhale, R. V., & Rathi, K. M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.003 · Cited by 34
Transdermal Delivery of Treatment for Alzheimer’s Disease
Chan, A. L. F., Chien, Y. W., & Lin, S. J. (2008) · Drugs & Aging · doi:10.2165/00002512-200825090-00003 · Cited by 32
Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease
Hriday, K. D. (2007) · Frontiers in bioscience · doi:10.2741/2723 · Cited by 34
Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression
Qin, J., Zhang, X., Wang, Z., Li, J., Zhang, Z., Gao, L., Ren, H., Qian, M., & Du, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-0347-4 · Cited by 32
Indirect Regulation of Presenilins in CREB-mediated Transcription
Watanabe, H., Smith, M. J., Heilig, E. A., Beglopoulos, V., Kelleher, R. J., & Shen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809168200 · Cited by 31
Self-citation
Evolutionary History of Alzheimer Disease-Causing Protein Family Presenilins with Pathological Implications
Khan, A. A., Ali, R. H., & Mirza, B. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-020-09966-w · Cited by 31
Neuron‐specific deletion of presenilin enhancer2 causes progressive astrogliosis and age‐related neurodegeneration in the cortex independent of the Notch signaling
Bi, H., Zhou, C., Zhang, Y., Cai, X., Ji, M., Yang, J., Chen, G., & Hu, Y. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13454 · Cited by 31
Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer’s disease in an induced neuron
Kim, H., Yoo, J., Shin, J., Chang, Y., Jung, J., Jo, D., Kim, J., Jang, W., Lengner, C. J., Kim, B., et al. (2017) · Brain · doi:10.1093/brain/awx144 · Cited by 30
Convergence of Presenilin- and Tau-Mediated Pathways on Axonal Trafficking and Neuronal Function
Peethumnongsin, E., Li, Y., Kallhoff, V., Hu, L., Takashima, A., Pautler, R. G., & Zheng, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1964-10.2010 · Cited by 30
Conditional Deletion of Notch1 and Notch2 Genes in Excitatory Neurons of Postnatal Forebrain Does Not Cause Neurodegeneration or Reduction of Notch mRNAs and Proteins
Zheng, J., Watanabe, H., Wines-Samuelson, M., Zhao, H., Gridley, T., Kopan, R., & Shen, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349738 · Cited by 29
Self-citation
Trafficking in neurons: Searching for new targets for Alzheimer's disease future therapies
Musardo, S., Saraceno, C., Pelucchi, S., & Marcello, E. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.019 · Cited by 29
Pen-2 Negatively Regulates the Differentiation of Oligodendrocyte Precursor Cells into Astrocytes in the Central Nervous System
Hou, J., Bi, H., Ye, Z., Huang, W., Zou, G., Zou, X., Shi, Y. S., Shen, Y., Ma, Q., Kirchhoff, F., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2455-19.2021 · Cited by 29
A novel function for the presenilin family member spe-4: inhibition of spermatid activation in Caenorhabditis elegans.
Gosney, R., Liau, W., & LaMunyon, C. W. (2008) · BMC Developmental Biology · doi:10.1186/1471-213x-8-44 · Cited by 29
Flies as the ointment: Drosophila modeling to enhance drug discovery
Bell, A. J., McBride, S. M. J., & Dockendorff, T. C. (2009) · Fly · doi:10.4161/fly.3.1.7774 · Cited by 30
Presenilins and the γ-secretase: still a complex problem
Small, D. H., Klaver, D. W., & Foa, L. C. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-7 · Cited by 29
Presenilin/γ-secretase and inflammation
Saura, C. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00016 · Cited by 30
Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03475-z · Cited by 28
Intramembrane proteolysis within lysosomes
Schröder, B., & Säftig, P. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.012 · Cited by 28
Multifunctional nano-enabled delivery systems in Alzheimer's disease management
Qian, C., Yuan, C., Li, C., Liu, H., & Wang, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00756k · Cited by 28
Effects of presenilin-1 familial Alzheimer’s disease mutations on γ-secretase activation for cleavage of amyloid precursor protein
Do, H. N., Devkota, S., Bhattarai, A., Wolfe, M. S., & Miao, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-04539-1 · Cited by 27
Mouse Models of Alzheimer’s Dementia: Current Concepts and New Trends
Torres‐Alemán, I. (2008) · Endocrinology · doi:10.1210/en.2008-0905 · Cited by 28
Familial Frontotemporal Dementia-Associated Presenilin-1 c.548G>T Mutation Causes Decreased mRNA Expression and Reduced Presenilin Function in Knock-In Mice
Watanabe, H., Xia, D., Kanekiyo, T., Kelleher, R. J., & Shen, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0317-12.2012 · Cited by 28
Self-citation
Structure and dynamics of γ-secretase with presenilin 2 compared to presenilin 1
Dehury, B., Tang, N., Blundell, T. L., & Kepp, K. P. (2019) · RSC Advances · doi:10.1039/c9ra02623a · Cited by 27
Insights into membrane-bound presenilin 2 from all-atom molecular dynamics simulations
Dehury, B., Tang, N., & Kepp, K. P. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1655481 · Cited by 27
Computing the Pathogenicity of Alzheimer’s Disease Presenilin 1 Mutations
Tang, N., Dehury, B., & Kepp, K. P. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00896 · Cited by 23
Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo
Giliberto, L., d’Abramo, C., Acker, C. M., Davies, P., & D'adamio, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011609 · Cited by 25
Animal Models of Alzheimer’s Disease
Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 25
β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling
Liu, W., Sun, F.-X., Wan, M., Jiang, F., Xiangyu, B. O., Lin, L., Tang, H., & Xu, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00969 · Cited by 24
A quantitative model of human neurodegenerative diseases involving protein aggregation
Kepp, K. P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.04.001 · Cited by 23
An Evolutionarily Conserved Role of Presenilin in Neuronal Protection in the Aging Drosophila Brain
Kang, J., Shin, S. J., Perrimon, N., & Shen, J. (2017) · Genetics · doi:10.1534/genetics.116.196881 · Cited by 24
Self-citation
Effect of glycogen synthase kinase 3 β-mediated presenilin 1 phosphorylation on amyloid β production is negatively regulated by insulin receptor cleavage
Maesako, M., Uemura, K., Kubota, M., Hiyoshi, K., Andō, K., Kuzuya, A., Kihara, T., Asada, M., Akiyama, H., & Kinoshita, A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.017 · Cited by 24
Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice
Mirnics, K., Norstrom, E. M., Garbett, K., Choi, S., Zhang, X., Ebert, P., & Sisodia, S. S. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-14 · Cited by 23
Molecular Insights into Cell Type-specific Roles in Alzheimer’s Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling
Qu, W., Canoll, P., & Hargus, G. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.006 · Cited by 24
Clinical proteomics in neurodegenerative diseases
Zhou, J., Hanfelt, J., & Peng, J. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700378 · Cited by 23
N‐cadherin‐based adhesion enhances Aβ release and decreases Aβ42/40 ratio
Uemura, K., Lill, C. M., Banks, M., Asada, M., Aoyagi, N., Andō, K., Kubota, M., Kihara, T., Nishimoto, T., Sugimoto, H., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05760.x · Cited by 22
Mechanism-based treatments for Alzheimer's disease
Davies, P., & Koppel, J. L. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/pdavies · Cited by 23
Differential and substrate-specific inhibition of γ-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4
Hou, X., Zhang, X., Zou, H., Guan, M., Fu, C., Wang, W., Zhang, Z.-R., Geng, Y., & Chen, Y. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.024 · Cited by 23
Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia
Rostgaard, N., Waldemar, G., Nielsen, J. E., & Simonsen, A. H. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000381828 · Cited by 23
CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer’s Disease Skin Fibroblasts
Inoue, K., Oliveira, L. M. A., & Abeliovich, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.075 · Cited by 24
Kv channel-interacting proteins as neuronal and non-neuronal calcium sensors
Bähring, R. (2018) · Channels · doi:10.1080/19336950.2018.1491243 · Cited by 22
An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products
Firdaus, Z., & Singh, T. D. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200730155928 · Cited by 23
A computer-simulated mechanism of familial Alzheimer’s disease: Mutations enhance thermal dynamics and favor looser substrate-binding to γ-secretase
Dehury, B., Somavarapu, A. K., & Kepp, K. P. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107648 · Cited by 22
Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate γ-Secretase Activities
Futai, E., Osawa, S., Cai, T., Fujisawa, T., Ishiura, S., & Tomita, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.629287 · Cited by 22
Amyloid-β Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau
Nizzari, M., Barbieri, F., Gentile, M. T., Passarella, D., Caorsi, C., Diaspro, A., Taglialatela, M., Pagano, A., Colucci-D'Amato, L., Florio, T., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101590 · Cited by 21
Dominant negative mechanism of Presenilin-1 mutations in FAD
Watanabe, H., & Shen, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717180114 · Cited by 21
Self-citation
Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pathology, Constitute a Potential Object for Early Diagnosis
López-Toledo, G., Silva‐Lucero, M., Herrera‐Díaz, J., García, D.-E., Arias‐Montaño, J., & Cárdenas‐Aguayo, M. D. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.921573 · Cited by 20
The Cleavage Domain of the Amyloid Precursor Protein Transmembrane Helix Does Not Exhibit Above‐Average Backbone Dynamics
Pester, O., Götz, A., Multhaup, G., Scharnagl, C., & Langosch, D. (2013) · ChemBioChem · doi:10.1002/cbic.201300322 · Cited by 21
Chemical and morphological alterations of spines within the hippocampus and entorhinal cortex precede the onset of Alzheimer's disease pathology in double knock‐in mice
Aoki, C. J., Mahadomrongkul, V., Fujisawa, S., Habersat, R., & Shirao, T. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21485 · Cited by 21
Dysregulation of Hypoxia-Inducible Factor by Presenilin/γ-Secretase Loss-of-Function Mutations
Kaufmann, M. R., Barth, S., Konietzko, U., Wu, B., Egger, S. S., Kunze, R., Marti, H. H., Hick, M., Müller, U., Camenisch, G., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3402-12.2013 · Cited by 21
Presenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2
Wang, W., Moerman, A., Slaton, A., & Barger, S. W. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.005 · Cited by 23
Computational analysis of Alzheimer-causing mutations in amyloid precursor protein and presenilin 1
Mehra, R., & Kepp, K. P. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108168 · Cited by 20
Membrane dynamics of γ‐secretase with the anterior pharynx‐defective 1B subunit
Dehury, B., & Kepp, K. P. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29832 · Cited by 20
Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release
Servián‐Morilla, E., Robles-Lanuza, E., Sánchez-Hidalgo, A. C., Camacho-Garcia, R. J., Paez-Gomez, J. A., Mavillard, F., Saura, C. A., Martı́nez-Mir, A., & Scholl, F. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-17.2017 · Cited by 20
Redox signaling in the pathogenesis of human disease and the regulatory role of autophagy
Pervaiz, S., Bellot, G. L., Lemoine, A., & Brenner, C. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.03.002 · Cited by 23
Cell-autonomous role of Presenilin in age-dependent survival of cortical interneurons
Kang, J., & Shen, J. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00419-y · Cited by 20
Self-citation
The Role of Presenilin in Protein Trafficking and Degradation—Implications for Metal Homeostasis
Greenough, M. A. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0826-4 · Cited by 19
Increased adult neurogenesis associated with reactive astrocytosis occurs prior to neuron loss in a mouse model of neurodegenerative disease
Liu, T., Ye, X., Zhang, J., Yu, T., Cheng, S., Zou, X., Xu, Y., Chen, G., & Yin, Z. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12763 · Cited by 19
Presenilin/γ-secretase-dependent EphA3 processing mediates axon elongation through non-muscle myosin IIA
Javier‐Torrent, M., Marco, S., Rocandio, D., Pons-Vizcarra, M., Janes, P. W., Lackmann, M., Egea, J., & Saura, C. A. (2019) · eLife · doi:10.7554/elife.43646 · Cited by 19
Contributive Role of Hyperglycemia and Hypoglycemia Towards the Development of Alzheimer’s Disease
Chakrabarty, R., Yousuf, S., & Singh, M. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02846-y · Cited by 20
Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice
Côtel, M.-C., Bayer, T. A., & Wirths, O. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.052 · Cited by 19
High content analysis of γ-secretase activity reveals variable dominance of presenilin mutations linked to familial Alzheimer's disease
Florean, C., Zampese, E., Zanese, M., Brunello, L., Ichas, F., Giorgi, F. D., & Pizzo, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.03.012 · Cited by 19
Tau pathology and neurodegeneration: An obvious but misunderstood link
Delacourte, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14412 · Cited by 18
Autophagy in alzheimer disease pathogenesis and its therapeutic values
Angst, G., Jia, N., Esqueda, L. T., Fan, Y., Cai, Q., & Wang, C. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2471677 · Cited by 22
The Development of an in vivo γ-Secretase Assay using Zebrafish Embryos
Wilson, L., & Lardelli, M. T. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130332 · Cited by 18
Monoamine Oxidase-A Physically Interacts with Presenilin-1(M146V) in the Mouse Cortex
Wei, Z.-L., Gabriel, G. G., Rui, L., Cao, X., Pennington, P. R., Chlan‐Fourney, J., Nazarali, A., Baker, G., & Mousseau, D. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111241 · Cited by 18
A Preliminary Study: PS1 Increases U1 snRNA Expression Associated with AD
Cheng, Z., Du, Z., Shang, Y., Zhang, Y., & Zhang, T. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0932-y · Cited by 18
Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice
Chen, C., Wang, H., Qian, F., Liu, M.-H., Guo, X.-X., Lv, J., Huang, J.-H., Zhang, N.-Z., & Xiang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.939039 · Cited by 18
Alzheimer's disease and related dementias
Hardy, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.003 · Cited by 18
Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model.
Malthankar‐Phatak, G. H., Lin, Y., Giovannone, N., & Siman, R. G. (2012) · Europe PMC (PubMed Central) · Cited by 18
Presenilin conditional double knockout mice exhibit decreases in drebrin a at hippocampal CA1 synapses
Lee, D. E., & Aoki, C. J. (2012) · Synapse · doi:10.1002/syn.21578 · Cited by 18
The Drosophila DmGluRA is required for social interaction and memory
Schoenfeld, B. P., Choi, R. J., Choi, C. H., Terlizzi, A. M., Hinchey, P., Kollaros, M., Ferrick, N. J., Koenigsberg, E., Ferreiro, D., Leibelt, D. A., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00064 · Cited by 17
Structural and Chemical Biology of Presenilin ComplexesPreprint
Johnson, D. S., Li, Y., Pettersson, M., & George‐Hyslop, P. S. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024067 · Cited by 21
Loss of Presenilin 2 Function Is Associated with Defective LPS-Mediated Innate Immune Responsiveness
Agrawal, V., Sawhney, N., Hickey, E., & McCarthy, J. V. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9285-0 · Cited by 18
Presenilin 1 mutation likely contributes to U1 small nuclear RNA dysregulation and Alzheimer's disease–like symptoms
Cheng, Z., Shang, Y., Xu, X., Dong, Z., Zhang, Y., Du, Z., Lu, X., & Zhang, T. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.015 · Cited by 17
Decrease in catalytic capacity of γ-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease
Svedružić, Ž. M., Popović, K., & Jengić, V. Š. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.06.002 · Cited by 17
Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies
Drzezga, A. E. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0697-6 · Cited by 17
Ibuprofen Rescues Abnormalities in Periodontal Tissues in Conditional Presenilin 1 and Presenilin 2 Double Knockout Mice
Su, J., Gu, J., Dong, Z., & Mei, B. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918457 · Cited by 16
In Vivo Application of an RNAi Strategy for the Selective Suppression of a Mutant Allele
Kubodera, T., Yamada, H., Anzai, M., Ohira, S., Yokota, S., Hirai, Y., Mochizuki, H., Shimada, T., Mitani, T., Mizusawa, H., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.054 · Cited by 16
Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases
Chung, Y.-H., Lin, C.-W., Huang, H., Chen, S.-L., Huang, H.-J., Sun, Y., Lee, G.-C., Lee‐Chen, G., Chang, Y.-C., & Hsieh‐Li, H. M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01521-y · Cited by 17
News about Therapies of Alzheimer’s Disease: Extracellular Vesicles from Stem Cells Exhibit Advantages Compared to Other Treatments
Meldolesi, J. (2022) · Biomedicines · doi:10.3390/biomedicines10010105 · Cited by 16
Increased levels of NMDA receptor NR2A subunits at pre‐ and postsynaptic sites of the hippocampal CA1: An early response to conditional double knockout of presenilin 1 and 2
Aoki, C. J., Lee, J., Nedelescu, H., Ahmed, T. H., Ho, A., & Shen, J. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22151 · Cited by 18
Self-citation
Early-Onset Alzheimer Disease in an Italian Family With Presenilin-1 Double Mutation E318G and G394V
Batelli, S., Albani, D., Prato, F., Polito, L., Franceschi, M., Gavazzi, A., & Forloni, G. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815a9dec · Cited by 16
RETRACTED: The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects
Liu, L., Liang, J., Liu, Y.-H., Liu, B., Dong, X., Cai, W.-H., & Zhang, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30523 · Cited by 15
Retracted
Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro
Pennington, P. R., Wei, Z.-L., Rui, L., Doig, J., Graham, B., Kuski, K., Gabriel, G. G., & Mousseau, D. (2011) · Journal of neural transmission · doi:10.1007/s00702-011-0616-7 · Cited by 15
Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders
Cohen, E., Moll, L., & Elami, T. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13917 · Cited by 15
Aβ and the dementia syndrome: Simple versus complex perspectives
Hunter, S., Smailagic, N., & Brayne, C. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13025 · Cited by 15
Presenilins Regulate Neurotrypsin Gene Expression and Neurotrypsin-dependent Agrin Cleavage via Cyclic AMP Response Element-binding Protein (CREB) Modulation*
Almenar-Queralt, A., Kim, S., Benner, C., Herrera, C., Kang, D. E., Garcia-Bassets, I., & Goldstein, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.513705 · Cited by 15
Neuronal Migration and Neurodegeneration: 2 Sides of the Same Coin
Reiner, O., Shmueli, A., & Sapir, T. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp039 · Cited by 16
Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
Área-Gómez, E., & Schon, E. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231318 · Cited by 18
Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease
Ngoc, A. P. T., Zahoor, A., Kim, D., & Yang, S. H. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2403.03021 · Cited by 16
Efficient four‐drug cocktail therapy targeting amyloid‐β peptide for Alzheimer's disease
Asai, M., Iwata, N., Tomita, T., Iwatsubo, T., Ishiura, S., Saido, T. C., & Maruyama, K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22503 · Cited by 15
Bax inhibitor 1 is a γ-secretase–independent presenilin-binding protein
Wu, S., Song, W., Wong, C. C. L., & Shi, Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810870116 · Cited by 14
A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer’s Disease Increases Aβ42/Aβ40 ratio
Qiu, Q., Shen, L., Jia, L., Wang, Q., Li, F., Li, Y., & Jia, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181291 · Cited by 14
Can Anti–β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?
Imbimbo, B. P., Lucca, U., & Watling, M. I. L. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000535 · Cited by 15

Authors: Shen, J., & Kelleher, R. J.
Affiliations: Brigham and Women's Hospital (US)
Harvard University (US)
ORCID: Shen, Jie
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2007-01-09
Volume: 104
Issue: 2
Pages: 403-409
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0608332104
PMC: PMC1766397
OpenAlex: W2041601288
Cited by: 485
References: 62
Citations by year: 2026: 9 · 2025: 14 · 2024: 22 · 2023: 32 · 2022: 16 · 2021: 20 · 2020: 31 · 2019: 21 · 2018: 19 · 2017: 26 · 2016: 24 · 2015: 20 · 2014: 14 · 2013: 31 · 2012: 32
FWCI: 3.36
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer's Association
National Institutes of Health
National Institute of Neurological Disorders and Stroke (RF1NS041783, R01NS041783)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: presenilin, Alzheimer's disease, familial Alzheimer's disease, loss-of-function mechanism, amyloid precursor protein, amyloid-beta, amyloid-beta 42, Aβ40, gamma-secretase, gamma-secretase inhibitors, conditional knockout mice, memory loss, neurodegeneration, frontotemporal dementia, presenilin mutations
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Disease Models, Animal, Humans, Models, Neurological, Molecular Sequence Data, Mutation, Nerve Degeneration, Amyloid beta-Protein Precursor, Mice, Knockout, Mice, Presenilins, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The presenilin hypothesis of Alzheimer’s disease: Evidence for a loss-of-function pathogenic mechanism.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks